Wells Fargo & Company Spectrum Pharmaceuticals Inc Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$0.65 - $1.31 $3,077 - $6,201	-4,734 Reduced 1.28%	365,931 $351,000
Q1 2023 May 12, 2023	SELL	$0.38 - $1.07 $4,419 - $12,445	-11,631 Reduced 3.04%	370,665 $277,000
Q4 2022 Feb 13, 2023	SELL	$0.32 - $0.52 $15,384 - $25,000	-48,078 Reduced 11.17%	382,296 $141,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $1.56 $2,213 - $8,030	-5,148 Reduced 1.18%	430,374 $185,000
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.4 $19,834 - $39,669	-28,335 Reduced 6.11%	435,522 $340,000
Q1 2022 May 16, 2022	SELL	$0.63 - $1.59 $50,570 - $127,630	-80,271 Reduced 14.75%	463,857 $599,000
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $4,927 - $9,389	-3,880 Reduced 0.71%	544,128 $691,000
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $43,000 - $76,400	-20,000 Reduced 3.52%	548,008 $1.19 Million
Q2 2021 Aug 16, 2021	SELL	$2.89 - $4.45 $372,769 - $573,987	-128,986 Reduced 18.51%	568,008 $2.13 Million
Q1 2021 May 13, 2021	BUY	$2.9 - $4.09 $126,695 - $178,683	43,688 Added 6.69%	696,994 $2.27 Million
Q4 2020 Feb 09, 2021	BUY	$3.38 - $5.14 $47,249 - $71,852	13,979 Added 2.19%	653,306 $2.23 Million
Q3 2020 Nov 05, 2020	SELL	$2.99 - $4.9 $281 - $460	-94 Reduced 0.01%	639,327 $2.61 Million
Q2 2020 Aug 13, 2020	BUY	$2.11 - $3.38 $32,512 - $52,082	15,409 Added 2.47%	639,421 $2.16 Million
Q1 2020 May 14, 2020	BUY	$1.83 - $3.45 $1.14 Million - $2.15 Million	624,012 New	624,012 $1.45 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.